The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.

The agency is proposing that device manufacturers improve their testing to including larger, more diverse sample sizes.

All entries were placed in a draw for one free registration to the TCT meeting and two Platinum memberships for TCTMD.

The proportion of female speakers increased over time, but they remain underrepresented in procedural and other specialties.

In dialysis-dependent patients, those on denosumab for fracture risk had a 36% higher MACE rate than those on bisphosphonates ...

The findings are consistent with prior research showing that counties lacking these services have poorer CV outcomes.

The device was not included as a potential treatment despite sham-controlled evidence showing it reduces patient symptoms.

With the pandemic having worsened burnout and intent to leave, the authors say keeping and supporting the workforce is ...

Large, practice-changing clinical trials—those presented at the big cardiology meetings—made up half of our most-read stories. But the other contenders in 2024 reflect more quotidian concerns of TCTMD ...